| A Phase I Study of a Therapeutic Vaccine Candidate in Patients With Localized Breast Cancer at High-Risk of Relapse (NCT02364492) | Institut Pasteur | 2015-02-01 |
| Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer (NCT02278965) | Katherine D. Crew | 2015-01-22 |
| Vaccination of High Risk Breast Cancer Patients (NCT02229084) | University of Arkansas | 2015-01-14 |
| Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer (NCT02309177) | Celgene | 2015-01-12 |
| A Study on Neoadjuvant Therapy for Her-2 Positive Breast Cancer and the Prognosis by Detecting CTCs (NCT02510781) | Hospital Affiliated to Military Medical Science, Beijing | 2015-01-01 |
| Relational and Emotional Mechanisms of a Supportive-expressive Group Intervention in Breast Cancer (NCT02934815) | Universidade do Porto | 2015-01-01 |
| A Culturally Sensitive Social Support Intervention (NCT02946697) | M.D. Anderson Cancer Center | 2015-01-01 |
| Safety and Efficacy Study of Mix Vaccine in Breast Carcinoma Patient (NCT02338804) | Fuda Cancer Hospital, Guangzhou | 2015-01-01 |
| The Canadian/US Integrative Oncology Study (NCT02494037) | The Canadian College of Naturopathic Medicine | 2015-01-01 |
| Ambulatory SNP Under Local Anaesthesia in a Subgroup of Breast Cancer Patients - Trial (NCT02187718) | Medical Center Alkmaar | 2015-01-01 |
| Antibiotic Prophylaxis in Oncological Surgery of Breast (NCT02809729) | Fabiola Soares Moreira Campos | 2015-01-01 |
| Multiple B-value Diffusion-weighted Imaging(DWI) in Evaluation of Breast Lesions (NCT02529384) | Tang-Du Hospital | 2015-01-01 |
| AR-inhibitor Bicalutamide in Treating Patients With TNBC (NCT02353988) | Jinling Hospital, China | 2015-01-01 |
| Evaluation of Cryoprotection Induced Nail Toxicity Docetaxel Low Cumulative Dose (NCT02283983) | Centre Hospitalier Departemental Vendee | 2014-12-01 |
| Study of Epigallocatechin-3-gallate (EGCG) for Skin Prevention in Patients With Breast Cancer Receiving Adjuvant Radiotherapy (NCT02580279) | Shandong Cancer Hospital and Institute | 2014-12-01 |
| Smart-phone Health Coaching Intervention to Promote Maintenance of Exercise in Breast Cancer Survivors:Protocol (NCT02620735) | University Health Network, Toronto | 2014-12-01 |
| Preoperative Relaxation Training and Acupuncture to Minimize Perioperative Symptoms in Breast Cancer Patients (NCT02276404) | Universität Duisburg-Essen | 2014-11-01 |
| Study Assessing The Interest of Indocyanine Green Fluorescence Imaging With Radioisotope Method For Sentinel Lymph Node Biopsy in Patients With Breast Cancer (NCT02279108) | Centre Hospitalier Universitaire de Saint Etienne | 2014-11-01 |
| Intra-operative Radiotherapy For Breast Cancer Women After NSM (NCT02389686) | Liao Ning | 2014-10-01 |
| Cognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT Study (NCT03270995) | McGill University | 2014-10-01 |
| Intra-operative Radiotherapy For Women With Ductal Carcinoma in Situ Breast Cancer (NCT02389673) | Liao Ning | 2014-10-01 |
| Prevention of Female Cancers by Optimization of Selenium Levels in the Organism. (NCT04014283) | Read-Gene S.A. | 2014-10-01 |
| Acute Pain Trajectories and Persistent Pain After Breast Cancer Surgery (NCT02823015) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2014-10-01 |
| Argon Plasma Coagulation Scalpel on Surgical Treatment of Breast Cancer (NCT02548338) | Federal University of São Paulo | 2014-09-01 |
| Perioperative Inflammation and Breast Cancer Outcome (NCT02141139) | Samsung Medical Center | 2014-09-01 |
| A Study Assessing the Safety and Efficacy of Adding Ipatasertib to Paclitaxel Treatment in Participants With Breast Cancer That Has Spread Beyond the Initial Site, and the Cancer Does Not Have Certain Hormonal Receptors (NCT02162719) | Genentech, Inc. | 2014-08-19 |
| Paclitaxel and BKM120 Before Surgery in Treating Patients With Stage II or III Estrogen Receptor-Positive and HER2-Negative Breast Cancer (NCT01953445) | Washington University School of Medicine | 2014-08-01 |
| ForeCYTE Breast Aspirator for Sample Collection and Cytological Testing of Nipple Aspirate Fluid (NCT02218385) | Atossa Therapeutics, Inc. | 2014-08-01 |
| A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer (NCT02107703) | Eli Lilly and Company | 2014-07-22 |
| Clinical Study for the Treatment of Breast Cancer: the Patient Will Receive Afatinib Plus Letrozole or Letrozole Alone (NCT02115048) | Translational Research in Oncology | 2014-07-01 |
| Diagnosis of Pathological Complete Response by Minimal Invasive Biopsy After Neoadjuvant Chemotherapy in Breast Cancer (NCT02575612) | Heidelberg University | 2014-07-01 |
| Evaluating Outcomes of Immediate Breast Reconstruction (POBRAD-M) (NCT02557906) | King's College London | 2014-07-01 |
| A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer (NCT02131064) | Hoffmann-La Roche | 2014-06-25 |
| Omitting Completion Axillary Treatment in Sentinel Node Positive Breast Cancer Patients Undergoing a Mastectomy (NCT02112682) | Maastricht University Medical Center | 2014-06-01 |
| Comparison of Intra-operative Radiotherapy With Post-operative Radiotherapy for Women With Ductal Carcinoma in Situ (NCT02389699) | Liao Ning | 2014-06-01 |
| Post-Treatment Surveillance in Breast Cancer: Bringing CER to the Alliance (NCT02171078) | University of Wisconsin, Madison | 2014-06-01 |
| ShearWave™ Elastography of Breast Lesions in Chinese Patients (NCT02226081) | SuperSonic Imagine | 2014-06-01 |
| Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors (NCT02077933) | Novartis Pharmaceuticals | 2014-05-14 |
| Laser InGaAlP (660Nm) to Prevent Radiodermatitis in Breast Cancer Patients Submitted to Radiation Therapy (NCT02003599) | Universidade do Vale do Sapucai | 2014-05-01 |
| Investigation of Diagnostic Improvement Gained Through Optimization of MR Methods for Breast Cancer Detection (NCT02411760) | University of Texas Southwestern Medical Center | 2014-05-01 |
| Prediction of Everolimus-induced Interstitial Lung Disease (NCT01978171) | Radboud University Medical Center | 2014-05-01 |
| Single Fraction High-Gradient Partial Breast Irradiation in Treating Patients With Low-Risk Stage 0-I Breast Cancer (NCT02076074) | Washington University School of Medicine | 2014-04-02 |
| Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004) (NCT01953536) | Endocyte | 2014-04-01 |
| LDE225 in Treating Patients With Stage II-III Estrogen Receptor- and HER2-Negative Breast Cancer (NCT01757327) | Washington University School of Medicine | 2014-04-01 |
| A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors (NCT02145559) | University of Chicago | 2014-04-01 |
| PICTURE Breast L: Patient Information Combined for Local Therapy oUtcome Assessment in bREast Cancer - Longitudinal (NCT02341820) | University College, London | 2014-04-01 |
| A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread (NCT02057133) | Eli Lilly and Company | 2014-03-10 |
| Testing BRCA 1/2 Mutation Using Next Generation Sequencing (NCT02151747) | Severance Hospital | 2014-02-01 |
| Prevention of Breast Cancer Recurrence Through Weight Control, Diet, and Physical Activity Intervention (NCT02035631) | Institut Català d'Oncologia | 2014-01-01 |
| Effect of Exercise Training in Autonomic Modulation in Breast Cancer Patients (NCT02584712) | Federal University of Maranhao | 2014-01-01 |
| The Use of Smart Scales for Weight Gain Prevention in African American Breast Cancer Survivors (NCT02030353) | UNC Lineberger Comprehensive Cancer Center | 2014-01-01 |
| Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells (NCT01779050) | Washington University School of Medicine | 2013-12-19 |
| A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study) (NCT02034916) | Pfizer | 2013-12-13 |
| Exploring Biological Linkage Between Circadian Disruption and Cancer Progression (NCT02011815) | Seoul National University Hospital | 2013-11-10 |
| A Study of Trastuzumab Subcutaneous in Participants With Human Epidermal Growth Factor Receptor-2 (HER2) Positive Early Breast Cancer (NCT01959386) | Hoffmann-La Roche | 2013-11-07 |
| Capsule Biopsy in Acellular Dermal Matrix-based Prosthetic Breast Reconstruction: a Prospective Pilot Study (NCT03744273) | Samsung Medical Center | 2013-11-03 |
| Phase 2 Study of Adjuvant Radiotherapy in Breast Cancer Using a Once a Week Hypofractionated Regimen (NCT01965483) | Instituto do Cancer do Ceara | 2013-11-01 |
| Cancer and Anesthesia: Survival After Radical Surgery - a Comparison Between Propofol or Sevoflurane Anesthesia (NCT01975064) | Uppsala University | 2013-11-01 |
| Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBC (NCT01917279) | Binghe Xu | 2013-10-01 |
| Evaluation of Myocardial Changes During BReast Adenocarcinoma Therapy to Detect Cardiotoxicity Earlier With MRI (NCT02306538) | University Health Network, Toronto | 2013-10-01 |
| Evaluation of Survival in Patients With Metastatic Breast Cancer Receiving High-dose Chemotherapy With Autologous Haematopoietic Stem Cell Transplantation (NCT02860585) | Institut Paoli-Calmettes | 2013-09-27 |
| Relationship Between Genetic Polymorphism and Postoperative Nausea and Vomiting in Chinese Han Population (NCT03705026) | Fujian Medical University Union Hospital | 2013-09-01 |
| The Prognostic Value of FDG PET/CT and Diffusion-weighed Imaging on Breast Cancer (NCT01942759) | Bagcilar Training and Research Hospital | 2013-09-01 |
| A Study Of PF-06263507 In Patients With Advanced Solid Tumors (NCT01891669) | Pfizer | 2013-08-08 |
| Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib (NCT01875666) | UNC Lineberger Comprehensive Cancer Center | 2013-08-05 |
| Single Versus Multiple Injection Ultrasound Guided Paravertebral Blocks (NCT02852421) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2013-08-01 |
| Influence of Exceptional Patient Characteristics on Everolimus Exposure (NCT01948960) | Radboud University Medical Center | 2013-08-01 |
| Step by Step: A Tailored Walking Intervention for Breast Cancer Survivors (NCT01845519) | Leanne Kaye | 2013-07-01 |
| Assessment of Breast Cancer Response to Neoadjuvant Anthracycline-based Chemotherapy by FDG-PET and Molecular Markers (NCT02600442) | Assistance Publique - Hôpitaux de Paris | 2013-07-01 |
| A Study to Evaluate Denosumab in Young Patients With Primary Breast Cancer (NCT01864798) | Jules Bordet Institute | 2013-07-01 |
| Breast Cancer Long-term Outcome of Cardiac Dysfunction (NCT01904331) | University Medical Center Groningen | 2013-06-01 |
| Neoadjuvant ECS Versus ECF in Local Advanced Breast Cancer (NCT01849380) | Shandong University | 2013-06-01 |
| Comparison of Diagnostic Performance of Digital Breast Tomosynthesis and Ultrasound in Women With Dense Breasts (NCT01910103) | Seoul National University Hospital | 2013-06-01 |
| Eribulin Mesylate Phase IV Clinical Trial in Korean Patients With Metastatic or Locally Advanced Breast Cancer (NCT01961544) | Eisai Korea Inc. | 2013-06-01 |
| Exercise and Radiotherapy, a Good Combination? (NCT01908023) | Norwegian University of Science and Technology | 2013-05-01 |
| PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer (NCT01723774) | Washington University School of Medicine | 2013-04-10 |
| Axillary Ultrasound With or Without Sentinel Lymph Node Biopsy in Detecting the Spread of Breast Cancer in Patients Receiving Breast Conservation Therapy (NCT01821768) | Washington University School of Medicine | 2013-04-04 |
| Clinical Trial: Effectiveness and Efficiency of Physical Exercise in Cancer Patients (NCT01786122) | Basque Health Service | 2013-04-01 |
| Wound Infections in Breast Cancer Surgery After Preoperative Skin Preparation With Chlorhexidine vs. Povidone-iodine (NCT02479347) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2013-03-01 |
| Effect of the Nursing Intervention "Spiritual Support" (NCT01866670) | University of Sao Paulo | 2013-03-01 |
| Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR (NCT02043184) | Michigan State University | 2013-03-01 |
| A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2) (NCT01740427) | Pfizer | 2013-02-22 |
| Treatment of Primary Breast Cancer Using PDT (NCT02872064) | University College, London | 2013-01-01 |
| Preventing Seroma Formation After Axillary Lymph Node Dissection for Breast Cancer by Early Vacuum Assisted Closure (NCT01731769) | Changhai Hospital | 2013-01-01 |
| Comparison of Stationary Breast Tomosynthesis and 2-D Digital Mammography in Patients With Known Breast Lesions (NCT01773850) | UNC Lineberger Comprehensive Cancer Center | 2013-01-01 |
| Study Of PF-04691502 (PI3K/mTOR Inhibitor) In Combination With Exemestane Compared With Exemestane Alone In Patients With Advanced Breast Cancer (NCT01658176) | Pfizer | 2013-01-01 |
| Neoadjuvant Tamoxifen in Locally Advanced Breast Cancer in a Low/Middle Income Country (NCT02806544) | Vanderbilt University | 2013-01-01 |
| Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer (NCT01670877) | Washington University School of Medicine | 2012-12-11 |
| A Study of Genetic Based Chemotherapy Dosing for Breast Cancer Patients (NCT01740271) | AHS Cancer Control Alberta | 2012-12-01 |
| Iyengar Yoga for Chemotherapy-induced Fatigue in Breast Cancer Patients (NCT01686737) | Universität Duisburg-Essen | 2012-11-01 |
| Fertility Preservation in Breast Cancer Patients (NCT02661932) | Erasme University Hospital | 2012-11-01 |
| PREgnancy and FERtility Registry (NCT02895165) | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | 2012-11-01 |
| A Study Of Oral Palbociclib (PD-0332991), A CDK4/6 Inhibitor, As Single Agent In Japanese Patients With Advanced Solid Tumors Or In Combination With Letrozole For The First-Line Treatment Of Postmenopausal Japanese Patients With ER (+) HER2 (-) Advanced Breast Cancer (NCT01684215) | Pfizer | 2012-10-19 |
| Does Autologous Fat Transplantation Improve Results and Reduce Complications in Breast Reconstruction With Implants? (NCT02637635) | Karolinska Institutet | 2012-10-01 |
| Aromatase Inhibitor Host Factors Study (NCT01669343) | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | 2012-10-01 |
| Lapatinib With Trastuzumab in Treating Patients With HER2-Negative/HER2 Mutant Metastatic Breast Cancer (NCT01557764) | Washington University School of Medicine | 2012-09-01 |
| GRN1005 for Brain Metastases From Breast or Lung Cancer (NCT01679743) | National Cancer Institute (NCI) | 2012-08-29 |
| A Study to Assess the Ability of a Novel Endocrine Treatment for Breast Cancer, Irosustat, to Slow Down Cancer Growth (NCT01662726) | Imperial College London | 2012-08-01 |
| Phase I Trial of Afatinib and Trastuzumab in HER2 Overexpressing Cancer. (NCT01649271) | Boehringer Ingelheim | 2012-07-23 |
| The Ghana Breast Health Study (NCT01661023) | National Cancer Institute (NCI) | 2012-07-19 |